Amarin Corp Plc (AMRN)

[wmjenkins3938]

Yes and once ANCHOR is approved almost all Lovaza's will be off label in contrast to Vascepa. That combined with Lovaza's LDL problem will require all physicians,insurance companies, text books, protocols to require Vascepa. Might be a lot of Lovaza reps but nothing they can say, just supply free lunch.